Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome

Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome

(2012) G. J. GLAS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression

(2012) Andre C Kalil et al.   LANCET INFECTIOUS DISEASES

Drotrecogin Alfa (Activated) in Adults with Septic Shock

(2012) V. Marco Ranieri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Modulation of Coagulation and Fibrinolysis in Acute Lung Injury and the Acute Respiratory Distress Syndrome

(2011) Sara C. Sebag et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome

(2009) Alexander D Cornet et al.   Expert Opinion on Drug Discovery

Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury

(2008) Kathleen D. Liu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE